PEMF therapy for Arthritis & Osteo Recovery
PEMF therapy for arthritis is proven to alleviate pain and stimulate recovery. Almost every bone health issue such as arthritis, osteoarthritis, rheumatoid arthritis (RA), osteoporosis, fibromyalgia, among many other orthopedic disorders are benefited with the use of regular Pulsed electromagnetic field therapy.
PEMF therapy has been extensively researched for arthritis since more than 2 decades. Let’s look at some of the PEMF research on arthritis to understand the effects of this novel wellness and rehabilitation therapy.
PEMF therapy for Arthritis in Arthritis Foundation’s Guide to Alternative Therapies
PEMF therapy benefits arthritis due to the ability to decrease pain and increase mobility in the joints. The Arthritis Foundation’s Guide to Alternative Therapies reports two studies showing the benefits of PEMFs with osteoarthritis (OA) of the knee.
One was done at Yale University in 1993, a double blind, placebo-controlled pilot study1 involving 27 people with OA of the knee. It showed that those who got 18 half-hour treatments had an average improvement of 23 to 61 percent in pain, joint tenderness and discomfort. The placebo group getting fake treatments had only two to 18 percent improvement. The next study2 from 1999, with 167 patients with OA of the knee or cervical spine showed similar, significant improvements.
Conclusive Evidence of Effectiveness of PEMF for Arthritis & Bone Health
Rapid regeneration of bones and cartilages occurs with regular use of PEMF therapy for Arthritis along with appropriate nutrition and supplements. Chronic joint and bone problems start reversing and users report being able to be their younger selves again.
A double blind, placebo-controlled study3 was also done at Johns Hopkins University where 78 patients with OA of the knee had four weeks of treatments or a placebo. The treated group had significantly better results in terms of pain, function and physician assessment than the placebo group.
In 2016, Oxford Rheumatology published a paper4 where the results suggest that PEMF therapy is effective for pain management in knee OA patients and also affects pain threshold and physical functioning.
Further research studies are presented in the PEMF for arthritis bibliography at the bottom of this post.567891011 You may find even more research, PEMF therapy is side-effect free and a natural way to enhance the cells of the entire body, no matter what the issue.
BioBalance is an ideal PEMF machine
Effective Pulsed Electromagnetic Field therapy’s effects are very much dependent on the application time, waveform and frequency. PEMF devices by BioBalance offer the most flexible and well researched broadband (more penetrative) wave forms and frequencies. BioBalance PEMF can be the most important tool in a bone health professional’s clinic as well as at home for anyone wanting to improve their bone, cartilage and joint wellness exponentially.
With more power than most other PEMF mats that cost twice as much, the BioBalance has been designed and developed in Germany. We have more than 30 years of experience in manufacturing high-tech wellness devices and it’s our mission to bring high-quality and most importantly effective and long-term PEMF therapy to the world. You’ll get 30-days trial as per our satisfaction guarantee and we deliver worldwide.
Disclaimer: BioBalance PEMF can not claim to treat any medical condition.
1.Trock D, Bollet A, Dyer R, Fielding L, Miner W, Markoll R. A double-blind trial of the clinical effects of pulsed electromagnetic fields in osteoarthritis. J Rheumatol. 1993;20(3):456-460. [PubMed]
2.Trock D, Bollet A, Markoll R. The effect of pulsed electromagnetic fields in the treatment of osteoarthritis of the knee and cervical spine. Report of randomized, double blind, placebo controlled trials. J Rheumatol. 1994;21(10):1903-1911. [PubMed]
3.Zizic T, Hoffman K, Holt P, et al. The treatment of osteoarthritis of the knee with pulsed electrical stimulation. J Rheumatol. 1995;22(9):1757-1761. [PubMed]
4.Bagnato G, Miceli G, Marino N, Sciortino D, Bagnato G. Pulsed electromagnetic fields in knee osteoarthritis: a double blind, placebo-controlled, randomized clinical trial. Rheumatology (Oxford). 2016;55(4):755-762. [PubMed]
5.Ganesan K, Gengadharan A, Balachandran C, Manohar B, Puvanakrishnan R. Low frequency pulsed electromagnetic field–a viable alternative therapy for arthritis. Indian J Exp Biol. 2009;47(12):939-948. [PubMed]
6.Veronesi F, Torricelli P, Giavaresi G, et al. In vivo effect of two different pulsed electromagnetic field frequencies on osteoarthritis. J Orthop Res. 2014;32(5):677-685. [PubMed]
7.Nelson F, Zvirbulis R, Pilla A. Non-invasive electromagnetic field therapy produces rapid and substantial pain reduction in early knee osteoarthritis: a randomized double-blind pilot study. Rheumatol Int. 2013;33(8):2169-2173. [PubMed]
8.Iannitti T, Fistetto G, Esposito A, Rottigni V, Palmieri B. Pulsed electromagnetic field therapy for management of osteoarthritis-related pain, stiffness and physical function: clinical experience in the elderly. Clin Interv Aging. 2013;8:1289-1293. [PubMed]
9.Bjordal J, Johnson M, Lopes-Martins R, Bogen B, Chow R, Ljunggren A. Short-term efficacy of physical interventions in osteoarthritic knee pain. A systematic review and meta-analysis of randomised placebo-controlled trials. BMC Musculoskelet Disord. 2007;8:51. [PubMed]
10.Chang W, Chen L, Sun J, Lin F. Effect of pulse-burst electromagnetic field stimulation on osteoblast cell activities. Bioelectromagnetics. 2004;25(6):457-465. [PubMed]
11.Fischer G, Pelka R, Barovic J. [Adjuvant treatment of knee osteoarthritis with weak pulsing magnetic fields. Results of a placebo-controlled trial prospective clinical trial]. Z Orthop Ihre Grenzgeb. 2005;143(5):544-550. [PubMed]
Targeting Mesenchymal Stromal Cells/Pericytes (MSCs) With Pulsed Electromagnetic Field (PEMF) Has the Potential to Treat Rheumatoid Arthritis
Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by chronic inflammation of synovium (synovitis), with inflammatory/immune cells and resident fibroblast-like synoviocytes (FLS) acting as major players in the pathogenesis of this disease. The resulting inflammatory response poses considerable risks as loss of bone and cartilage progresses, destroying the joint surface, causing joint damage, joint failure, articular dysfunction, and pre-mature death if left untreated. At the cellular level, early changes in RA synovium include inflammatory cell infiltration, synovial hyperplasia, and stimulation of angiogenesis to the site of injury. Different angiogenic factors promote this disease, making the role of anti-angiogenic therapy a focus of RA treatment. To control angiogenesis, mesenchymal stromal cells/pericytes (MSCs) in synovial tissue play a vital role in tissue repair. While recent evidence reports that MSCs found in joint tissues can differentiate to repair damaged tissue, this repair function can be repressed by the inflammatory milieu. Extremely-low frequency pulsed electromagnetic field (PEMF), a biophysical form of stimulation, has an anti-inflammatory effect by causing differentiation of MSCs. PEMF has also been reported to increase the functional activity of MSCs to improve differentiation to chondrocytes and osteocytes. Moreover, PEMF has been demonstrated to accelerate cell differentiation, increase deposition of collagen, and potentially return vascular dysfunction back to homeostasis. The aim of this report is to review the effects of PEMF on MSC modulation of cytokines, growth factors, and angiogenesis, and describe its effect on MSC regeneration of synovial tissue to further understand its potential role in the treatment of RA.
Objective: Pulsed electromagnetic field (PEMF) therapy is a potentially useful treatment for osteoarthritis (OA), but its effectiveness is still controversial. This study aimed to examine the effects of PEMF therapy and PEMF parameters on symptoms and quality of life (QOL) in patients with OA.
Methods: Cochrane Central Register of Controlled Trials, PubMed, CINAHL, EMBASE, PEDro, clinical trial registers, and reference lists were searched until April 2019. This study examined randomized, placebo-controlled trials, patients with OA, symptom and/or QOL related outcomes, and articles published in English. Two authors extracted data and completed quality assessment.
Results: Sixteen studies were included in our systematic review, while 15 studies with complete data were included in the meta-analysis. Our primary outcome was the standardized mean difference, which was equal to the treatment effect in the PEMF group minus the treatment effect in the placebo group divided by the pooled standard deviation. For pain, the standardized mean difference was 1.06 (95% CI = 0.61 to 1.51), for stiffness 0.37 (95% CI = 0.07 to 0.67), for function 0.46 (95% CI = 0.14 to 0.78), and for QOL 1.49 (95% CI = -0.06 to 3.04). PEMF parameters did not influence symptoms.
Conclusions: Compared with placebo, there was a beneficial effect of PEMF therapy on pain, stiffness, and physical function in patients with OA. Duration of treatment may not be a critical factor in pain management. Further studies are required to confirm the effects of PEMF therapy on QOL.
Impact: Our study suggests that PEMF therapy has clinically significant effects on pain in patients with OA. The current evidence was limited to the short-term effects of PEMF therapy.